NADMED Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
NADMED Ltd. - overview
Established
2022
Location
Helsinki, -, Finland
Primary Industry
Medical Devices & Equipment
About
Based in Helsinki, Finland, and founded in 2022 by co-founders Jari Narhi (CEO), Jana Buzkova, Liliya Euro, and Anu Wartiovaara MD, NADMED Ltd operates as a provider of advanced measurement kits for NAD and glutathione to clinical laboratories and research facilities, supporting accurate analysis and research. In August 2024, NADMED Ltd raised an undisclosed amount of grant funding from Business Finland Venture Capital. The company provides a wide range of laboratory services and measurement products, such as CE-marked assay kits for NAD+ and NADH from whole blood, tissue, or cells, NADP+ and NADPH assay kits, and NAD purity tests. Additionally, the firm also provides laboratory services for NAD and glutathione measurements in human and animal samples.
Current Investors
Voima Ventures, Helsinki University Funds, Nordic Science Investments
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Diagnostic Equipment
Website
www.nadmed.com/
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
NADMED Ltd. - financials
| Fiscal Year Ended | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|
| Revenue (USD) | - | - | - |
| % Revenue Growth (YoY) | - | - | - |
| EBITDA (USD) | - | - | - |
| Operating Income (USD) | - | - | - |
| Operating Margin | - | - | - |
| % EBITDA Margin | - | - | - |
| NET Income (USD) | - | - | - |
| % Net Margin | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.